Leerink, TD Cowen, Goldman Sachs, Stifel and Guggenheim acted as joint book running managers for the offering.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORKA:
- Oruka Therapeutics price target raised to $100 from $75 at UBS
- Oruka Therapeutics announces $500M common stock, warrants offering
- Oruka Therapeutics price target raised to $131 from $71 at Clear Street
- Morning News Wrap-Up, 4/27/26: Today’s Biggest Stock Market Stories!
- Oruka Therapeutics rises 19.0%